@gpentheroudakis.bsky.social
50 years, 50000 of us
🎉 50 years. 50,000 professionals. Advancing #oncology
🤝 A #GlobalCommunity of #OncologyProfessionals growing, collaborating and innovating through ESMO.
Together, we continue to turn progress into lasting impact, improving care for #PatientsWithCancer
🤝 A #GlobalCommunity of #OncologyProfessionals growing, collaborating and innovating through ESMO.
Together, we continue to turn progress into lasting impact, improving care for #PatientsWithCancer
December 29, 2025 at 6:56 PM
50 years, 50000 of us
The new ESMO Guideline on localised prostate cancer
📣 Updated ESMO #ClinicalPracticeGuideline on local & locoregional #ProstateCancer:
✅New imaging modalities: Improved diagnosis, staging & risk stratification
✅Updated algorithms: less over-Tx & fewer side-effects
#Oncology #UroOncology #CancerCare #ESMOGuidelines
🔗 https://ow.ly/jwA650XLs1q
✅New imaging modalities: Improved diagnosis, staging & risk stratification
✅Updated algorithms: less over-Tx & fewer side-effects
#Oncology #UroOncology #CancerCare #ESMOGuidelines
🔗 https://ow.ly/jwA650XLs1q
December 18, 2025 at 2:52 PM
The new ESMO Guideline on localised prostate cancer
Reposted
New Living Guideline on Early & Locally Advanced #NSCLC! This dynamic resource integrates all recommendations and algorithms from the recently updated #ClinicalPracticeGuideline, supporting clinicians in evidence-based decision-making for optimal patient care.
🔗 https://ow.ly/3Apq50XA60u
🔗 https://ow.ly/3Apq50XA60u
December 1, 2025 at 4:30 PM
New Living Guideline on Early & Locally Advanced #NSCLC! This dynamic resource integrates all recommendations and algorithms from the recently updated #ClinicalPracticeGuideline, supporting clinicians in evidence-based decision-making for optimal patient care.
🔗 https://ow.ly/3Apq50XA60u
🔗 https://ow.ly/3Apq50XA60u
Reposted
📣 New ESMO #Lymphomas Living Guideline v1.0.
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format.
🔗 https://ow.ly/wLFE50X7y9e
#ESMOGuidelines
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format.
🔗 https://ow.ly/wLFE50X7y9e
#ESMOGuidelines
October 16, 2025 at 9:00 AM
📣 New ESMO #Lymphomas Living Guideline v1.0.
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format.
🔗 https://ow.ly/wLFE50X7y9e
#ESMOGuidelines
Includes all recommendations and algorithms from the published #ClinicalPracticeGuideline, covering major lymphoma subtypes in an interactive format.
🔗 https://ow.ly/wLFE50X7y9e
#ESMOGuidelines
Our new ESMO CPG on localised NSC Lung Cancer is out!
📣 Updated ESMO #ClinicalPracticeGuideline on early & locally advanced #NSCLC: new systemic treatments, innovative strategies & advanced therapeutic options to personalise #PatientCare & improve outcomes.
🔗 buff.ly/Yn640wo
#LungCancer #SystemicTherapy #Oncology #CancerTreatment #ESMOGuidelines
🔗 buff.ly/Yn640wo
#LungCancer #SystemicTherapy #Oncology #CancerTreatment #ESMOGuidelines
August 28, 2025 at 8:54 AM
Our new ESMO CPG on localised NSC Lung Cancer is out!
Reposted
📣Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines
🔗 buff.ly/fvvPb26
🔗 buff.ly/fvvPb26
August 12, 2025 at 10:01 AM
📣Updated ESMO #ClinicalPracticeGuideline recommendations in #MetastaticBreastCancer: focusing on #PrecisionOncology and a #PatientCentricCare, this commentary highlights key updates of the ESMO Living Guideline algorithms, focusing on HR+/HER2- disease. #ESMOGuidelines
🔗 buff.ly/fvvPb26
🔗 buff.ly/fvvPb26
The ESMO Pan Lymphoma Clinical Practice Guideline!
📣 New ESMO #ClinicalPracticeGuideline on #lymphomas: evidence-based recommendations for all major #lymphoma subtypes, updated as needed as an ESMO Living Guideline, reflecting developments in Tx.
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #ESMOGuidelines
🔗 buff.ly/2ZYJc2c
#DLBCL #PCNSL #FollicularLymphoma #HodgkinLymphoma #ESMOGuidelines
🔗 buff.ly/2ZYJc2c
August 6, 2025 at 8:33 AM
The ESMO Pan Lymphoma Clinical Practice Guideline!
The ESMO Living Guideline is Live: Rectal cancer
👉 ESMO Living Guidelines on Localised Rectal Cancer: New title in the library with all recommendations and algorithms from the published Guideline in an interactive format.
#ESMOGuidelines
🔗 buff.ly/WFIOLUJ
#ESMOGuidelines
🔗 buff.ly/WFIOLUJ
July 7, 2025 at 1:45 PM
The ESMO Living Guideline is Live: Rectal cancer
Reposted
👉 ESMO Living Guidelines on Renal Cell Carcinoma v1.1: New title with updated recommendations and algorithms from the published Guideline in an interactive format.
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
June 13, 2025 at 8:15 AM
👉 ESMO Living Guidelines on Renal Cell Carcinoma v1.1: New title with updated recommendations and algorithms from the published Guideline in an interactive format.
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
🔗 buff.ly/JvkbDx8
@silkegillessen.bsky.social
ESMO with a new Rectal Cancer CPG!
📣 Updated ESMO #ClinicalPracticeGuideline on #localised #rectalcancer: situation-dependent intensification & de-intensification, complex radiological factors, #biomarkers & selective Tx goals via organ-preserving strategies form options & decisions
#ESMOGuidelines
🔗 buff.ly/GPnKSMY
#ESMOGuidelines
🔗 buff.ly/GPnKSMY
May 22, 2025 at 8:47 AM
ESMO with a new Rectal Cancer CPG!
Reposted
📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up.
🔗 buff.ly/dvDOsNK
@hemasphere-journal.bsky.social #ESMOGuidelines
🔗 buff.ly/dvDOsNK
@hemasphere-journal.bsky.social #ESMOGuidelines
May 8, 2025 at 2:17 PM
📣 Updated ESMO-EHA #ClinicalPracticeGuideline on management of ‘mature’ or ‘peripheral’ T- and NK-cell #lymphomas: 👉 clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up.
🔗 buff.ly/dvDOsNK
@hemasphere-journal.bsky.social #ESMOGuidelines
🔗 buff.ly/dvDOsNK
@hemasphere-journal.bsky.social #ESMOGuidelines
Reposted
📣 ESMO Living Guideline on Hepatocellular Carcinoma:
👉 New title with the latest recommendations and algorithms in an interactive format.
@ducreuxmichel.bsky.social
@arndtvogel.bsky.social
#ClinicalPracticeGuideline
🔗 buff.ly/ncdmYZ5
👉 New title with the latest recommendations and algorithms in an interactive format.
@ducreuxmichel.bsky.social
@arndtvogel.bsky.social
#ClinicalPracticeGuideline
🔗 buff.ly/ncdmYZ5
April 25, 2025 at 1:39 PM
📣 ESMO Living Guideline on Hepatocellular Carcinoma:
👉 New title with the latest recommendations and algorithms in an interactive format.
@ducreuxmichel.bsky.social
@arndtvogel.bsky.social
#ClinicalPracticeGuideline
🔗 buff.ly/ncdmYZ5
👉 New title with the latest recommendations and algorithms in an interactive format.
@ducreuxmichel.bsky.social
@arndtvogel.bsky.social
#ClinicalPracticeGuideline
🔗 buff.ly/ncdmYZ5
Reposted
📣ESMO Living Guidelines on Metastatic Breast Cancer:
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
April 18, 2025 at 9:11 AM
📣ESMO Living Guidelines on Metastatic Breast Cancer:
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
👉Just updated with the latest recommendations and algorithms in an interactive format.
🔗 buff.ly/JsHALyN
#ClinicalPracticeGuideline
Reposted
📣#ESMOAI25: The tools to navigate AI and digital health in oncology. Register today and contribute to the global conversation on responsible AI in cancer care.
⏰ Early registration deadline: 3 September 2025
🔗https://buff.ly/6jXHHO3
⏰ Early registration deadline: 3 September 2025
🔗https://buff.ly/6jXHHO3
April 2, 2025 at 1:01 PM
📣#ESMOAI25: The tools to navigate AI and digital health in oncology. Register today and contribute to the global conversation on responsible AI in cancer care.
⏰ Early registration deadline: 3 September 2025
🔗https://buff.ly/6jXHHO3
⏰ Early registration deadline: 3 September 2025
🔗https://buff.ly/6jXHHO3